VARANESE, SARA
 Distribuzione geografica
Continente #
EU - Europa 1.021
NA - Nord America 996
AS - Asia 561
SA - Sud America 37
AF - Africa 3
OC - Oceania 2
Totale 2.620
Nazione #
US - Stati Uniti d'America 993
CN - Cina 214
IT - Italia 208
SG - Singapore 203
UA - Ucraina 181
IE - Irlanda 155
GB - Regno Unito 116
TR - Turchia 99
FR - Francia 98
SE - Svezia 95
DE - Germania 87
FI - Finlandia 46
IN - India 40
BR - Brasile 35
RU - Federazione Russa 21
CH - Svizzera 5
IR - Iran 3
NL - Olanda 3
CA - Canada 2
EG - Egitto 2
NZ - Nuova Zelanda 2
RO - Romania 2
AT - Austria 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IQ - Iraq 1
LT - Lituania 1
MX - Messico 1
SI - Slovenia 1
TN - Tunisia 1
VE - Venezuela 1
VN - Vietnam 1
Totale 2.620
Città #
Jacksonville 218
Chandler 200
Singapore 163
Dublin 154
Southend 107
Princeton 83
Nanjing 65
Izmir 63
Santa Clara 37
Cambridge 35
Wilmington 32
Nanchang 30
Beijing 23
Dearborn 22
Ashburn 20
Altamura 18
The Dalles 16
Grevenbroich 15
Rome 15
Milan 14
Shenyang 13
Helsinki 11
Munich 10
Boardman 9
Hebei 9
Kunming 9
Ann Arbor 8
Taizhou 8
Augusta 7
Changsha 7
Genova 6
Jiaxing 6
Jinan 6
Leawood 6
Los Angeles 6
Norwalk 6
London 5
Monmouth Junction 5
Shanghai 5
Tianjin 5
Changchun 4
Chiasso 4
Falls Church 4
Lanzhou 4
Ningbo 4
Appiano Gentile 3
Boretto 3
Caserta 3
Catania 3
Guangzhou 3
Nova Iguaçu 3
Sammichele di Bari 3
San Mateo 3
São Paulo 3
Washington 3
Zhengzhou 3
Alexandria 2
Aosta 2
Ardabil 2
Arezzo 2
Belo Horizonte 2
Campobasso 2
Cesano Maderno 2
Clifton 2
Florence 2
Hangzhou 2
Houston 2
Mistretta 2
Mumbai 2
Napoli 2
New York 2
Nürnberg 2
Orange 2
Poggio Picenze 2
Porto Torres 2
Rovereto 2
Spoltore 2
Torino 2
Villanova Del Ghebbo 2
Alessandria 1
Andover 1
Antea 1
Assaí 1
Auckland 1
Baghdad 1
Bangalore 1
Bari 1
Barra 1
Bologna 1
Brasília 1
Campo Novo do Parecis 1
Candia Lomellina 1
Capua 1
Casoria 1
Casteldaccia 1
Chennai 1
Christchurch 1
Cornaredo 1
Dallas 1
Dolo 1
Totale 1.597
Nome #
La Mattis Dementia Rating Scale e la NPI messi al confronto nella valutazione della malattia di Alzheimer, demenza a corpi di Lewy diffusa e la malattia di Parkinson con Demenza, in una popolazione del centro Italia. 222
Bipallidal lesions induce delayed and progressive parkinsonism 95
Camptocormia nella Malattia di Parkinson e nella demenza a corpi di Lewy 89
Two novel POLG1 mutations in a patient with progressive external ophthalmoplegia, levodopa-responsive pseudo-orthostatic tremor and parkinsonism. 83
EEG comparison in early AD, LBD, PDD patients with a 2 years follow-up. 83
End-of-dose deterioration in non ergolinic dopamine agonist monotherapy of Parkinson's disease. 80
Camptocormia in Lewy Body disease (LBD) in comparison with Parkinson’s Disease (PD) 80
Fluctuating cognition and different cognitive and behavioural profiles in Parkinson's disease with dementia: comparison of dementia with Lewy bodies and Alzheimer's disease. 77
PSI proteasome inhibitor induced rat model of Parkinson’s Disease. 76
Camptocormia in Lewy Body Disease (LBD) in comparison with Parkinson’s Disease (PD). 75
Cortical rhythms in ad, LBD and normal subjects: A quantitative meg study 75
Attention modulation regulates both motor and non-motor performance: a high-density EEg study in parkinson's disease 74
Irrelevant features of a stimulus can either facilitate or disrupt performance in a working memory task: The role of fluid intelligence. 74
Behavioural assessment of dysexecutive syndrome in Parkinson's disease without dementia: A comparison with other clinical executive tasks. 73
Clinical and electrohysiological analysis of the fluctuating cognition in patients affected by Dementia with Lewy Bodies. 71
Protracted benefit from paradoxical kinesia in typical and atypical parkinsonisms. 70
Cortical rhythms in ad, lbd and normal subjects: a quantitative MEG study 70
Catamenial end-off dose in Parkinson's disease 69
Un caso di sindrome disesecutiva in una paziente sottoposta ad STN-DBS: follow-up da 0 a 10 mesi 68
EEG comparison in early AD, LBD, PDD patients with a 2-year follow-up 67
PSI induce proteasome inhibition and motor disturbances in rats 67
Acetyl-L-carnitine:from a biological curiosity to a drug for the peripheral nervous system and beyond. 67
Responsiveness of dysphagia to acute L-Dopa challenge in progressive supranuclear palsy 67
Electrophysiological indices of interference resolution covary with individual fluid intelligence:investigating reactive control processes in 3-back working memory task. 66
Camptocormia in Lewy body disease (LBD) in comparison with Parkinson's disease (PD) 65
Study of mitochondrial function in a psi-induced model of parkinson’s disease. 64
Levetiracetam in patients with chronic epilepsy: the seizure outcome 63
PSI produce l’inibizione del proteasoma causando disturbi motori in ratti 63
Cohort study of prevalence and phenomenology of tremor in dementia with Lewy bodies. 58
Incidence of RBD and hallucination in patients affected by Parkinson's disease 58
End –off dose catameniale nella malattia di Parkinson 51
Hedonistic homeostatic dysregulation in Parkinson s Disease: Prevalence and incidence. Alzheimer’s and Parkinson’s disease: Insights, progress and perspectives 51
Pathophysiology of Mental Disturbances in Parkinsonism 50
Botulinum toxin treatment of lateral axial dystonia in Parkinsonism 50
Pathophysiology of mental Disturbances in Parkinsonism 48
Pathophysiology of mental disturbances in parkinsonism 48
Modafinil and armodafinil improve attention and global mental status in Lewy bodies disorders: preliminary evidence 46
Totale 2.653
Categoria #
all - tutte 10.938
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.938


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202049 0 0 0 0 0 0 0 0 0 0 48 1
2020/2021242 39 5 39 2 8 44 6 7 26 33 31 2
2021/2022155 3 1 4 26 9 3 6 18 7 7 23 48
2022/2023544 45 72 40 40 52 109 34 35 85 6 9 17
2023/2024195 14 17 11 3 10 43 66 2 3 4 0 22
2024/2025420 32 155 115 3 8 19 17 14 21 34 2 0
Totale 2.653